Jump to main content
Jump to site search

Issue 21, 2014
Previous Article Next Article

Quantification of an exogenous cancer biomarker in urinalysis by Raman Spectroscopy

Author affiliations

Abstract

We quantified an exogenous cancer biomarker, Acetyl amantadine (AcAm), directly from urine solution using surface enhanced Raman spectroscopy (SERS). SERS was used for the detection of AcAm using a commercial Raman substrate after beta-cyclodextrin encapsulation for capture of the analyte. We achieved a detection limit of 1 ng mL−1 of AcAm in the mock urine in the absence of steroids without extraction or other pre-treatment methods required. With levels of corticosterone typical of urine, the limit of detection was 30 times higher. Since the approach works directly from samples containing the high concentrations of salts and organic co-solutes normal to urine, it has the potential to reduce cost and speed up processing with respect to methods that require pre-purification. Therefore, this is promising for clinical adoption for early cancer detection, particularly for lung cancer.

Graphical abstract: Quantification of an exogenous cancer biomarker in urinalysis by Raman Spectroscopy

Back to tab navigation

Supplementary files

Article information


Submitted
19 Jul 2014
Accepted
19 Aug 2014
First published
19 Aug 2014

Analyst, 2014,139, 5375-5378
Article type
Paper
Author version available

Quantification of an exogenous cancer biomarker in urinalysis by Raman Spectroscopy

G. Cao, G. Hajisalem, W. Li, F. Hof and R. Gordon, Analyst, 2014, 139, 5375
DOI: 10.1039/C4AN01309C

Social activity

Search articles by author

Spotlight

Advertisements